Skip to the page

Data / Form D filings / Legend Biotech Corp

Legend Biotech Corp: Form D filings

Legend Biotech Corp, a biotechnology company in Somerset, NJ, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on April 28, 2023, reports $200 million sold of a $200 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2101 COTTONTAIL LANE, Somerset, NJ, 08873
Phone
(732) 317-5050
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Cayman Islands
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1801198

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 28, 2023New notice$200,000,005$200,000,0051Apr 19, 2023sec.gov
Apr 7, 2020New notice$160,450,000$150,450,000$10,000,0008Mar 30, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Li Wai Man Mao, MDDirector
Tomas Wai Man HeymanDirector
Fangliang Zhang, Ph.D.Director
Darren Xiaohui Ji, M.D., Ph.D.Director
Li Zhu, Ph.D.Director
Lori MacomberExecutive Officer
Patrick Wai Man Casey, Ph.D.Director
Ye Wang, M.S.Director
Philip Wai Man Yau, CPADirector
Ying Huang, Ph.D.Executive Officer, Director
Corazon D. Sanders, Ph.D.Director

Other biotechnology companies in New Jersey that filed recently

Every Form D from the week of Apr 24, 2023 · All recent filings in New Jersey · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Legend Biotech Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.